TNFRSF12A and amyotrophic lateral sclerosis: This suggest that the detrimental effect of the aberrant activity of the TWEAK/Fn14 pathway in skeletal muscle of SOD1G93A ALS mice is driven by the receptor (Fn14) and not the ligand (TWEAK).